• The Journal of the Korea Contents Association
• /
• v.20 no.1
• /
• pp.668-674
• /
• 2020

Quality Assurance (QA) is essential to provide effective hyperthermia, but in the case of a problem with a hyperthermia cancer therapy system in Korea, the manufacturers or venders are repairing and maintaining the system. In Korea, if an error occurs in the hyperthermia system, the manufacturer and sales agent are repairing and maintaining it. There is no QA protocol suitable for the domestic situation. This study is based on the QA guidelines recommended by institutions such as European Society for Hyperthermia Oncology (ESHO), Hellenic Society of Oncologic Hyperthermia (HSOH), and the results of questionnaires to hospitals that have hyperthermia cancer therapy systems in Korea. By developing an optimized QA protocol, we aim to reduce the errors and inaccuracies that can occur in during hyperthermia such as measurement of temperature, instrumentation, and heat transfer. In addition, we will visit a hospital with a hyperthermia cancer therapy system in Korea to perform a QA based on this study, and study to specify tolerances and accurate QA set-up parameters using the measured QA results.

• The Journal of Korean Society for Radiation Therapy
• /
• v.2 no.1
• /
• pp.7-17
• /
• 1987

• Radiation Oncology Journal
• /
• v.2 no.2
• /
• pp.167-171
• /
• 1984

The renewed interest in the use of hyperthermia in cancer therapy is based on radiobiological and clinical evidence indicating that there may be significant thereapeutic advantages with the use of hyperthermia alone or combined with irradiation plus heat. Authors performed the experiment using the chemically induced mammary carcinoma of rats to observe the difference in temperature changes between tumor and normal tissue during heat, and to compare the response of the tumors to radiation alone and to radiation plus hyperthermia. The results were as follows 1. Temperature of tumors was significantly higher than in the normal tissue during heating and the difference was about $1.5^{\circ}C$. 2. $TCD_{50}$ in radiation alone and hyperthermia immediately following radiation was 1,282 rad and 795 rad, respectively and TER value was 1.81.

• Radiation Oncology Journal
• /
• v.7 no.2
• /
• pp.157-169
• /
• 1989

Radiological and clinical evidences indicate that hyperthermia combined with irradiation produce a significant improvement in therapeutic effect of cancer The experiences obtained from 90 rats' kidney A single dose of irradiation ranged from 6Gy, 8Gy and 10Gy was delivered on the rat's kidney. The combined therapy group had the same irradiation after hyperthermia at $42\~44^{\circ}C$ for 30 minutes. Microscopic examination and calculation of thermal enhancement ratio were carried out, and the results were as follows: 1. In the group of hyperthermia alone, there were moderate glomerular congestion and mild tubular degeneration on light microscopic examination. 2. In the group of irradiation alone, tubular degeneration was noted in 6Gy irradiation and its severity was increased along with radiation dose. 3. In the group of hyperthermia combined with irradiation, tubular degeneration and necrosis were appeared in 6Gy and 10Gy irradiation, respectively. 4. On electron microscopic examination, proximal convoluted tubular and glomerular changes in irradiation group were similar to that of combined with hyperthermia, and its severity was increased along with observation periods. 5. Thermal enhancement ratio (TER) was 1.0 after evaluation of histipathologic changes in rat's kidney, with combination therapy.

• Journal of electromagnetic engineering and science
• /
• v.5 no.3
• /
• pp.126-131
• /
• 2005

To increase the efficiency of an applicator during microwave hyperthermia therapy, first, the length from the antenna end to a slot is varied to get the optimal matching of the characteristic impedance at the frequency of 2.45 GHz. Using the electric and thermal constants of biological tissue, we compose a phantom to calculate temperature increment as well as the resonance characteristics and the SAR distributions. The proposed 3-slot sleeve antenna inserted in an applicator plays an effective role in increasing the therapy size in the view of heating performance as electromagnetic energy tends to concentrate on not feed point direction but treatment area. The SAR is then used in combination with a finite difference heat transfer equation to determine the temperature distribution. Also, in order to shorten treatment time and increase therapy size, a square-array structure is suggested and analyzed.

• Asian Pacific Journal of Cancer Prevention
• /
• v.14 no.4
• /
• pp.2307-2310
• /
• 2013

Curcumin previously was proven to inhibit angiogenesis and display potent antitumor activity in vivo and in vitro. In the present study, we investigated whether a combination curcumin with hyperthermia would have a synergistic antitumor effect in the LL/2 model. The results indicated that combination therapy significantly inhibited cell proliferation of MS-1 and LL/2 in vitro. LL/2 experiment model also demonstrated that the combination therapy inhibited tumor growth and prolonged the life span in vivo. Furthermore, combination therapy reduced angiogenesis and increased tumor apoptosis. Our findings suggest that the combination therapy exerted synergistic antitumor effects, providing a new perspective fpr clinical tumor therapy.

• Proceedings of the KOSOMBE Conference
• /
• v.1985 no.06
• /
• pp.9-12
• /
• 1985

This paper covers the design and implementation process of RF hypertermia system for cancer therapy. Among many hyperthermic methods, RF capacitive heating method is discussed because it can heat the deep-seated tumors selectively. The RF power oscillator and its applicators were designed and implemented. And the experiments were performed with agar phantom and dog to prove that the system can heat any depth selectively. And the electrical safety and appropriateness of clinical application was proved through the human living-body test.

• Herbal Formula Science
• /
• v.27 no.1
• /
• pp.45-52
• /
• 2019

Objectives : Hyperthermia is a widely used therapeutic tool for cancer therapy and a well-known inducer of apoptosis. Although the Cinnamomi cortex (CC) is a potent anticancer agent for several human carcinomas, it is less potent in the human U937 cell line. To explore any enhancing effects of CC with hyperthermia induced apoptosis, this study investigated the combined effects and apoptotic mechanisms of hyperthermia and CC in U937 cells. Methods : U937 cells were heat treated at $43^{\circ}C$ for 30 min with or without pre-treatment for 1h with CC and then incubated at $37^{\circ}C$ with 5% $CO_2$. Cell viability was analyzed by MTT assay and Trypan blue assay. Morphological changes reflecting apoptosis were visualized under microscope. Synergy effect of CC combined with hyperthermia were calculated by Compusyn software. The expression of proteins related to apoptosis and signaling pathways was determined by western blotting. Results : Hyperthermia with CC reduced cell viability and induced apoptosis. Combined hyperthermia and CC treatment markedly augmented apoptosis by upregulating proapoptotic proteins and suppressing antiapoptotic proteins, culminating in caspase-3 activation. Furthermore, the combined treatment, decreased the expression of in Bcl-2 family, cyclin D1, VEGF, MMP2 and MMP9 expression. Conclusion : This study provides compelling evidence that hyperthermia, in combination with CC, is a promising therapeutic strategy for enhancement of apoptosis and suggests a promising therapeutic approach for cancer.

• The Journal of the Acoustical Society of Korea
• /
• v.6 no.1
• /
• pp.29-38
• /
• 1987

In clinical applications of hyperthermia, temperatures can be measured at only a few locations, whereas accurate temperature profiles need to be known for efficient therapy. For doing this, bio-heat transfer equation was modified into 1 dimensional 2 boundary value problem for simplicity and the efficiency of time, and solved by Galerkin's method. The results were then applied to annular array transducer for both the calculation of its axial temperature distribution and the estimation of temperature profiles from a few measured temperature data.

• Asian Pacific Journal of Cancer Prevention
• /
• v.15 no.5
• /
• pp.2359-2362
• /
• 2014

Background: To investigate the effects of double radiofrequency hyperthermia on Th1/Th2 cells in esophageal cancer patients treated with radiotherapy. Materials and Methods: 22 patients with esophageal cancer were divided into a radiotherapy group (10 cases) and a combined group (double radiofrequency hyperthermia combined with radiotherapy group, 12 cases). Both groups received conventional radiotherapy using a cobalt-60 therapy apparatus (TD60-66Gy/30-33F). Patients in the combined group also underwent double radiofrequency hyperthermia (2F/W, 8-10F). Before and after treatment, Th1, Th2, Tc1 and Tc2 cells in peripheral blood were determined with flow cytometry. Results: In the radiotherapy group, Th1 cell contents before and after radiotherapy were $17.5{\pm}5.26%$ and $9.69{\pm}4.86%$, respectively, with a significant difference (p<0.01). The Th1/Th2 ratio was significantly decreased from $28.2{\pm}14.3$ to $16.5{\pm}10.4 $(p<0.01). In the combined group, Th1 cell content before radiotherapy was $15.9{\pm}8.18%$, and it increased to $18.6{\pm}8.84$ after radiotherapy (p>0.05), the Th1/Th2 ratio decreasing from $38.4{\pm}36.3$ to $28.1{\pm}24.0$ (p>0.05). Changes in Th2, Tc1 and Tc2 cell levels were not significant in the two groups before and after therapy (p>0.05). Conclusions: Double radiofrequency hyperthermia can promote the conversion from Th2 to Th1 cells, and regulate the balance of Th1/Th2 cells.